# Belle.ai

> Belle.ai (legally BelleTorus Corporation) is a Cambridge, Massachusetts company building AI that reads skin from an ordinary smartphone photo. Its Belle 1K Skin AI engine uses geometric image analysis to surface comparable references across more than 1,600 skin conditions and to produce objective severity scores for immune-mediated diseases like psoriasis, eczema, acne, vitiligo and alopecia. The goal is practical: give general practitioners, estheticians and providers in places with few dermatologists a tool to assess, document and track skin at the point of care. The technology is used across more than 60 countries and 1,000-plus provider sites, and the company has drawn contracts and recognition from ARPA-H and CMS.

- **Founded:** 2021
- **Headquarters:** Cambridge, Massachusetts, United States
- **Founders:** Ly Tran (Co-founder & CEO), Matthew Gloss (Co-founder & COO), Sylvain Dal-Mas (Co-founder & Director General, Europe), Jonathan Lowe (Co-founder & Chief Revenue Officer)
- **Team size:** ~42 employees
- **Products:** Belle 1K Skin AI, BellePro, Objective severity scoring, Esthetics / professional skincare tools
- **Notable:** Selected by CMS as one of six inaugural participants in the first CMS AI Demo Day (November 2024) from 300 applicants, Awarded a $3.5M ARPA-H contract to expand pediatric healthcare access using AI, Technology deployed across more than 60 countries and 1,000+ provider sites

## Products & services

- **Belle 1K Skin AI** — Core AI engine that uses geometric analysis of smartphone and dermoscopy images to surface comparable references across more than 1,600 skin conditions and variations.
- **BellePro** — Smartphone-based skin AI app for healthcare professionals that helps assess, document and triage dermatological cases at the point of care.
- **Objective severity scoring** — Standardized, objective scoring for immune-mediated skin conditions such as psoriasis, eczema, acne, vitiligo and alopecia areata, so providers can track progression over time.
- **Esthetics / professional skincare tools** — AI skin analysis tailored for estheticians and the professional beauty industry, bringing clinical-grade assessment into esthetic practice.

## Achievements

- Selected by CMS as one of six inaugural participants in the first CMS AI Demo Day (November 2024) from 300 applicants
- Awarded a $3.5M ARPA-H contract to expand pediatric healthcare access using AI
- Technology deployed across more than 60 countries and 1,000+ provider sites
- AI covers more than 1,600 skin conditions and variations from a smartphone photo
- Subject of a clinical study (NCT06724627) validating its dermatological image reference system in an active clinical setting

## Latest updates

- **2024-11** — Selected by CMS for its first Artificial Intelligence Demo Day; presented BellePro to federal health leaders.
- **2025-09** — Featured by the ARPA-H Investor Catalyst Hub for connecting with partners on its commercialization path.
- **2024-11** — Launched a clinical study (NCT06724627) applying its dermatological image reference system for patient diagnosis in an active clinical setting.

## Links

- Website: https://belle.ai
- LinkedIn: https://www.linkedin.com/company/belle-artificial-intelligence

---

Profile page: https://yespress.io/belle-ai
Published by YesPress — https://yespress.io
Last updated: 2026-07-07